| Takeda Pharma AG - Intuniv 2 mg, Retardtabletten | | 66130 | | 02 | | Intuniv 2 mg | | Retardtabletten | | C02AC02 | | Guanfacine | | 15.09.2017 | | |
| | Composition | | guanfacinum 2 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.071402 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 47.18 mg, povidonum K 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, pro compresso. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Guanfacinum | 2 mg |
| | BAG: Active Agent | Dose |
|---|
| Guanfacinum | 2 mg |
| | | | Inactive agents | Dose |
|---|
| Acidi Methacrylici | | | Acidum Fumaricum | | | Cellulosum Microcristallinum | | | Crospovidonum | | | Ethylis Acrylatis Polymerisatum | | | Glyceroli Dibehenas | | | Hypromellosum | | | Lactose Monohydrate | 47.18 mg | | Natrii Laurilsulfas | | | Polysorbatum 80 | | | Povidonum K | 30 | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
| |
| |
|
